Case Report: Mechanical Mitral Prosthetic Valve Thrombosis in the Context of COVID-19 Despite Effective Anticoagulation

Overview

Journal Eur Heart J Case Rep

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2022 Feb 11

PMID 35146323

Authors

Clarisse Jeckelmann

Bojan Djokic

Valerie Duchatelle

Gregoire Girod

Affiliations

Soon will be listed here.

Abstract

Background: The SARS-CoV2 virus has been an emerging virus since December 2019 and is the cause of a global pandemic whose clinical manifestations extend far beyond respiratory disease.

Case Summary: A patient with severe coronavirus disease 2019 respiratory infection, carrying a mechanical mitral valve and under anticoagulation, was admitted to our cardiology department because of a new atrial fibrillation, which turned out to be related to thrombosis of the mitral mechanical valve.

Conclusion: The pro-coagulant effect of the SARS-CoV2 virus does not spare patients at risk of thrombosis, even under effective anticoagulation. In patients with mechanical valves under vitamin K antagonist treatment, there is a high risk of thrombus formation. The treatment is based on thrombolysis by therapeutic anticoagulation, fibrinolysis, or surgery depending on the size, composition of thrombus, and clinical manifestation.

Citing Articles

Case report: a transcatheter aortic valve replacement failure secondary to COVID-19 infection.

Tacon P, Cao L, Birkeland K, Kedan I Eur Heart J Case Rep. 2023; 7(2):ytad054.

PMID: 36845835 PMC: 9949707. DOI: 10.1093/ehjcr/ytad054.

Screening the Potential Biomarkers of COVID-19-Related Thrombosis Through Bioinformatics Analysis.

Qi P, Huang M, Li T Front Genet. 2022; 13:889348.

PMID: 35692833 PMC: 9174658. DOI: 10.3389/fgene.2022.889348.

Successful use of ultraslow thrombolytic therapy in stuck mechanical aortic valve in a patient with COVID-19; a case report.

Al Helali S, Sandokji H, Al Moughari A, Al Ghamdi H, Assiri T, Al Amri H Int J Surg Case Rep. 2022; 95:107233.

PMID: 35617737 PMC: 9121637. DOI: 10.1016/j.ijscr.2022.107233.

References

Jacob M, Leal T, Soares P, de Matos Soeiro A . Mechanical Aortic Prosthetic Thrombosis in a 65-Year-Old Woman with SARS-CoV-2 Infection. Arq Bras Cardiol. 2021; 115(6):1180-1183. PMC: 8133743. DOI: 10.36660/abc.20200754. View

Bikdeli B, Madhavan M, Gupta A, Jimenez D, Burton J, Nigoghossian C . Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020; 120(7):1004-1024. PMC: 7516364. DOI: 10.1055/s-0040-1713152. View

Havers-Borgersen E, Butt J, Vinding N, Torp-Pedersen C, Gislason G, Kober L . Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis. J Thorac Cardiovasc Surg. 2019; 159(1):74-83.e4. DOI: 10.1016/j.jtcvs.2019.02.061. View

Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

Guillet H, Gallet R, Pham V, dHumieres T, Huguet R, Lim P . Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases. Eur Heart J Case Rep. 2021; 5(1):ytaa488. PMC: 7799310. DOI: 10.1093/ehjcr/ytaa488. View

Roudaut R, Serri K, Lafitte S . Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2006; 93(1):137-42. PMC: 1861363. DOI: 10.1136/hrt.2005.071183. View

Iba T, Levy J, Levi M, Thachil J . Coagulopathy in COVID-19. J Thromb Haemost. 2020; 18(9):2103-2109. PMC: 7323352. DOI: 10.1111/jth.14975. View

Otto C, Nishimura R, Bonow R, Carabello B, Erwin 3rd J, Gentile F . 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 143(5):e35-e71. DOI: 10.1161/CIR.0000000000000932. View

Dentali F, Riva N, Malato A, Saccullo G, Siragusa S, Ageno W . Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio. J Thorac Cardiovasc Surg. 2009; 137(1):91-3. DOI: 10.1016/j.jtcvs.2008.06.030. View

10.

Llopis Gisbert G, Vidal Urrutia V, Moruno Benita M, Paya Chaume A, Berenguer Jofresa A, Cubillos Arango A . Bioprosthetic Valve Thrombosis and Obstruction Secondary to COVID-19. Can J Cardiol. 2021; 37(6):938.e3-938.e6. PMC: 7585166. DOI: 10.1016/j.cjca.2020.10.008. View

11.

Gursoy M, Kalcik M, Yesin M, Karakoyun S, Bayam E, Gunduz S . A global perspective on mechanical prosthetic heart valve thrombosis: Diagnostic and therapeutic challenges. Anatol J Cardiol. 2016; 16(12):980-989. PMC: 5324921. DOI: 10.14744/AnatolJCardiol.2016.7486. View

12.

Buttard P, Bonnefoy E, Chevalier P, Marcaz P, Robin J, Obadia J . Mechanical cardiac valve thrombosis in patients in critical hemodynamic compromise. Eur J Cardiothorac Surg. 1997; 11(4):710-3. DOI: 10.1016/s1010-7940(96)01133-5. View

13.

Durrleman N, Pellerin M, Bouchard D, Hebert Y, Cartier R, Perrault L . Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg. 2004; 127(5):1388-92. DOI: 10.1016/j.jtcvs.2003.12.013. View

14.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

15.

Rico-Mesa J, Rosas D, Ahmadian-Tehrani A, White A, Anderson A, Chilton R . The Role of Anticoagulation in COVID-19-Induced Hypercoagulability. Curr Cardiol Rep. 2020; 22(7):53. PMC: 7298694. DOI: 10.1007/s11886-020-01328-8. View